Tag: Cell Analysis
China’s surge in antibody-drug conjugates positions it as key oncology market,...
ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.
Agilent to acquire BioTek, strengthen its leadership position in cell analysis...
Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis. BioTek is a recognized leader for plate-readers and imaging systems with complementary offerings to Agilent’s portfolio...........................